Strength of evidence of non-inferiority trials - The adjustment of the type I error rate in non-inferiority trials with the synthesis method

Statistics in Medicine

Volumn 29, Issue 14, 2010, Pages 1477-1487

  Kang, Seung Ho ^a   Tsong, Yi ^b  

^a Yonsei University   (South Korea)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Across trial type I error; Binary data; Correlation; Multivariate central limit theorem

Indexed keywords

NEW DRUG;

ARTICLE; EVIDENCE BASED MEDICINE; INFORMATION; STATISTICS;

COMPUTER SIMULATION; CONTROLLED CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS;

EID: 77953708859     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3903     Document Type: Article

References (14)

1. D'Agostino RB, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Statistics in Medicine 2003; 22:169-186.
2. Hung HM, Wang SJ, Tsong Y, Lawrence J, O'Neill R. Some fundamental issues for noninferiority testing in active controlled trials. Statistics in Medicine 2003; 22:213-225. (Pubitemid 36163582)
3. Tsong Y. The utility of active-controlled noninferiority/equivalence trials in drug development. International Journal of Pharmaceutical Medicine 2007; 21(3):225-233.
4. Holmgren EB. Establishing equivalence by showing that a specified percentage of the effect of the active control over placebo is maintained. Journal of Biopharmaceutical Statistics 1999; 9:651-659.
5. Hasselblad V, Kong D. Statistical methods for comparison to placebo in active-control trials. Drug Information Journal 2001; 35:435-449. (Pubitemid 32524896)
6. Rothmann M, Li N, Chen G, Temple R, Tsou R. Design and analysis of non-inferiority mortality trials in oncology. Statistics in Medicine 2003; 22:239-264. (Pubitemid 36163584)
7. Snapinn SM. Alternatives for discounting in the analysis of non-inferiority trials. Journal of Biopharmaceutical Statistics 2004; 14:263-273. (Pubitemid 38715780)
8. Tsong Y, Wang SJ, Hung HM. Statistical issues on objective, design and analysis of noninferiority active-controlled clinical trial. Journal of Biopharmaceutical Statistics 2003; 13:29-41. (Pubitemid 36254361)
9. Tsong Y, Levenson M, Zhang J, Zhong J. Choice of λ-margin and dependency of non-inferiority trials. Statistics in Medicine 2008; 27:520-528. (Pubitemid 351266339)
10. Hung HM, Wang SJ, O'Neill R. Issues with statistical risks for testing methods in non-inferiority trial without a placebo arm. Journal of Biopharmaceutical Statistics 2007; 17:201-213. (Pubitemid 46423595)
11. Tong YL. The Multivariate Normal Distribution. Springer: New York, 1990.
12. Hung HM, Wang SJ, O'Neill R. Challenges and regulatory experiences with non-inferiority trial design without placebo arm. Biometrical Journal 2009; 51(2):324-334.
13. Wang SJ, Hung HM, Tsong Y. Utility and pitfalls of some statistical methods in an active controlled trials. Controlled Clinical Trials 2002; 23:15-28. (Pubitemid 34164355)
14. Tsong Y, Zhang J, Levenson M. Choice of δ noninferiority margin and dependency of the noninferiority trials. Journal of Biopharmaceutical Statistics 2007; 17:279-288.